These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31451188)

  • 1. [Epigenetic alterations in kidney cancers].
    Helleux A; Debien V; Fadloun A; Rippinger M; Lebedinsky S; Davidson I; Malouf GG
    Bull Cancer; 2019 Oct; 106(10):839-841. PubMed ID: 31451188
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Connexin32 as a tumor suppressor gene in renal cell carcinoma].
    Fujimoto E; Yano T; Ueno K
    Nihon Yakurigaku Zasshi; 2007 Feb; 129(2):105-9. PubMed ID: 17299236
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
    Zhang Q; Jin J; Tao Q
    Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
    Linehan WM; Lerman MI; Zbar B
    JAMA; 1995 Feb; 273(7):564-70. PubMed ID: 7837390
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
    Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetics of oral cancer.
    Shaw R
    Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
    Singh NP; Vinod PK
    Mol Genet Genomics; 2020 May; 295(3):807-824. PubMed ID: 32185457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic analysis in the search for tumor suppressor genes.
    Han ZG
    Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative methylation profiling of renal tumors and the discovery of a new generation of molecular markers.
    Jerónimo C
    Future Oncol; 2005 Apr; 1(2):197-200. PubMed ID: 16555990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous and multiple renal cell carcinoma, clear cell and papillary: An approach to clinically significant genetic abnormalities.
    Cifuentes-C L; Martinez CH; Garcia-Perdomo HA
    Int Braz J Urol; 2020; 46(2):287-293. PubMed ID: 32022527
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
    Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
    Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary renal cell carcinoma and gastrointestinal stromal tumor: a unique association.
    Au WY; Ho KM; Shek TW
    Ann Oncol; 2004 May; 15(5):843-4. PubMed ID: 15111359
    [No Abstract]   [Full Text] [Related]  

  • 16. Genome-wide methylation analysis of tubulocystic and papillary renal cell carcinomas.
    Korabecna M; Geryk J; Hora M; Steiner P; Seda O; Tesar V
    Neoplasma; 2016; 63(3):402-10. PubMed ID: 26925785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA hypermethylation in papillary renal cell carcinoma.
    Ellinger J; Holl D; Nuhn P; Kahl P; Haseke N; Staehler M; Siegert S; Hauser S; Stief CG; Müller SC; Bastian PJ
    BJU Int; 2011 Feb; 107(4):664-9. PubMed ID: 20553257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
    Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours.
    Sanjmyatav J; Hauke S; Gajda M; Hartmann A; Moch H; Meyer B; Pryalukhin A; Grimm MO; Junker K
    Eur Urol; 2013 Oct; 64(4):689-91. PubMed ID: 23790440
    [No Abstract]   [Full Text] [Related]  

  • 20. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.